@FiercePharma: Prime time for reaching smartphone users? When they're waiting on a doc. More | Follow @FiercePharma
@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story from FierceBiotech | Follow @TracyStaton
@EricPFierce: Government won't let Indian drugmakers dump price capped 'essential drugs' if they control 1% of the market. Article | Follow @EricPFierce
@CarlyHFierce: Alere rethinks BBI IPO. Story via FierceDiagnostics | Follow @CarlyHFierce
> Cephalon, a unit of Teva Pharmaceutical Industries ($TEVA), persuaded a judge to toss out claims that it conspired with generics makers to delay copies of its wakefulness drug Provigil. Report
> Germany's Stada says it's in advanced talks to buy more over-the-counter drugs and other consumer health products in Britain and Eastern Europe. Report
> A California-based company that specializes in skin-patch drugs for osteoporosis plans to raise $65 million in an initial public offering. Report
> India's Dr. Reddy's Laboratories rolled out its version of AbbVie's ($ABBV) thyroid drug Zemplar (paricalcitol) in the U.S. Report
> U.S.-based generics maker Actavis ($ACT) is donating $25,000 to assist people affected by flooding in the northeastern region of Bulgaria, where it operates two plants. Report
> China's vaccine products company Sinovac said it won a reduction on its value-added tax rate to 3% from 6%. Release
> Indian securities regulators said they would closely monitor AstraZeneca's ($AZN) move to delist its Indian unit, on worries that checks on fraudulent and unfair trades were inadequate. Report
Medical Device News
@FierceMedDev: Abbott gets EU go-ahead for implant in aging eyes. More | Follow @FierceMedDev
@StacyALawrence: Study: 3D mammograms improve breast cancer detection. Story | Follow @StacyALawrence
@MichaelGFierce: Sinus drug delivery startup Intersect ENT files for $80 million IPO. News via the Silicon Valley Business Journal | Follow @MichaelGFierce
@EmilyWFierce: Hospital networks leaking data through misconfigured SMB service, leaving devices open to attack. Story from Wired | Follow @EmilyWFierce
> Newly public Inogen gains on FDA clearance for home oxygen device. More
> Medtronic picks exec to lead Covidien integration. Item
> Self-powered cardiac pacemaker a breakthrough for researchers. Story
> Study: 3D mammograms improve breast cancer detection. Article
Biotech News
@FierceBiotech: AbbVie makes its pitch for Shire buyout, U.K. tax gambit. More | Follow @FierceBiotech
@JohnCFierce: Talking to Shanghai-based biotech exec, going to do PhI in Australia because of better rep, faster regulatory decision on IND--says something. | Follow @JohnCFierce
@DamianFierce: J&J biz cards creating a sub-market at #BIO2014. Will trade for a Stoffels rookie card or hologram edition Gorsky. Picture | Follow @DamianFierce
@EmilyMFierce: Diagnostics maker Cepheid partners with AstraZeneca, Glaxo to combat antibiotic resistance. News | Follow @EmilyMFierce
> Affymax, once a promising biotech, is dissolving. Item
> FDA bars Basilea antibiotic from U.S. market, demands new PhIII data. More
> Versant's Inception plants its booming biotech startup model in Montreal. Story
Drug Delivery News
> Intersect ENT files for $80M IPO to support steroid-delivering sinus implants. More
> InVivo Therapeutics to ax hydrogel drug delivery program, cutting jobs. Story
> Self-healing hydrogel and ultrasound combo allows for 'on demand' delivery. Article
> FDA issues guidances on development of nanotechnology products. Report
> Microneedle patch reduces scar tissue in Singapore studies. Item
> Transdemeral delivery patchmaker Zosano to debut on Nasdaq. News
Diagnostics News
> Qiagen wins FDA OK for organ transplant test. More
> Roche lends Dx tech to Ferring for an infertility treatment. Article
> Cepheid partners with AstraZeneca, Glaxo on drug-resistant infections. News
> Definiens bags $20.4M for tissue diagnostics. Report
> Enzo scores $7M in patent battle with PerkinElmer. Item
> Alere rethinks BBI IPO. Story
Pharma Marketing News
> Novo Nordisk can double sales in a decade, deputy CEO says. Item
> Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land. Story
> Prime time for reaching smartphone users? When they're waiting on a doc. More
> FDA's social media translation for brand managers: Don't use Twitter. Article
> Can clot-fighters get a boost from the U.K.'s new enthusiasm? Report
> Amarin picks up Pawn Stars host to pitch its struggling fish-oil pill, Vascepa. News
And Finally... The polio virus has been detected in sewage in Brazil; it's the first time the disease has been identified in the country since 1994. Report